DeepMed Research

UNIVERSITY COLLEGE LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1826-02-11

Employees: 10K

Market Cap: -

Website: http://www.ucl.ac.uk

Clinical Trials

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Phase 2

Completed

Conditions: Secondary Progressive Multiple Sclerosis

Interventions: Drug: Placebo
Drug: Riluzole
Drug: Amiloride
Drug: Fluoxetine

First Posted Date: 2013-07-29

Last Posted Date: 2020-03-26

Lead Sponsor: University College, London

Target Recruit Count: 445

Registration Number: NCT01910259

Locations: 🇬🇧
Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, United Kingdom
🇬🇧
The Walton Centre, Liverpool, United Kingdom
🇬🇧
Derriford Hospital, Plymouth, United Kingdom

and more 10 locations

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

Active, not recruiting

Conditions: Non-small Cell Lung Cancer

First Posted Date: 2013-06-28

Last Posted Date: 2025-04-02

Lead Sponsor: University College, London

Target Recruit Count: 814

Registration Number: NCT01888601

Locations: 🇬🇧
Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey, Surrey, United Kingdom
🇬🇧
Heart of England NHS Foundation Trust, Birmingham, United Kingdom
🇬🇧
Cardiff and Vale University Health Board, Cardiff, United Kingdom

and more 15 locations

Study on the Impact of Stem Cell Donation and Bone Marrow Harvesting on Unrelated Donors

Completed

Conditions: Chromosome Aberrations

First Posted Date: 2013-06-24

Last Posted Date: 2013-06-24

Lead Sponsor: University College, London

Target Recruit Count: 50

Registration Number: NCT01884610

CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

Completed

Conditions: Viraemia

First Posted Date: 2013-06-21

Last Posted Date: 2017-10-27

Lead Sponsor: University College, London

Target Recruit Count: 48

Registration Number: NCT01883206

Locations: 🇬🇧
Royal Free Hospital, London, United Kingdom

Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size

Phase 3

Completed

Conditions: ST-elevation Myocardial Infarction

Interventions: Drug: placebo
Drug: Mineralocorticoid receptor antagonist potassium-canrenoate

First Posted Date: 2013-06-20

Last Posted Date: 2016-10-26

Lead Sponsor: University College, London

Target Recruit Count: 61

Registration Number: NCT01882179

Locations: 🇬🇧
Leeds Genereal Infirmary, Leeds, United Kingdom
🇬🇧
Cardiothoracic Center - Basildon and Thurrock University Hospitals, Basildon, Essex, United Kingdom
🇬🇧
London Chest Hospital, London, United Kingdom

and more 1 locations

Non-invasive Brain Stimulation and Cognitive Processing in Depression

Not Applicable

Completed

Conditions: Unipolar Major Depressive Disorder

Interventions: Device: Transcranial direct current stimulation (tDCS)
Behavioral: Cognitive Behavioural Therapy

First Posted Date: 2013-06-11

Last Posted Date: 2018-05-09

Lead Sponsor: University College, London

Target Recruit Count: 30

Registration Number: NCT01875419

Locations: 🇬🇧
UCL Institute of Cognitive Neuroscience, London, United Kingdom

Investigation Into the Role of GTN & RIPC in Cardiac Surgery

Phase 3

Completed

Conditions: Myocardial Reperfusion Injury

Interventions: Drug: IV Glyceryl trinitrate 2-5ml/h
Other: Remote ischaemic preconditioning
Drug: IV Normal saline

First Posted Date: 2013-05-29

Last Posted Date: 2019-09-25

Lead Sponsor: University College, London

Target Recruit Count: 192

Registration Number: NCT01864252

Locations: 🇬🇧
The Heart Hospital, UCL Hospitals NHS Trust, London, United Kingdom

The Medicines Advice Service Evaluation

Not Applicable

Completed

Conditions: Hyperlipidemias
Type 2 Diabetes

Interventions: Other: Medicines Advice Service

First Posted Date: 2013-05-29

Last Posted Date: 2015-05-27

Lead Sponsor: University College, London

Target Recruit Count: 677

Registration Number: NCT01864239

Locations: 🇬🇧
UCL School of Pharmacy, London, United Kingdom

The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study

Conditions: Chronic Stable Angina
ST Elevation Myocardial Infarction (STEMI)
Unstable Angina
Coronary Heart Disease Not Otherwise Specified
Intracerebral Haemorrhagic Stroke
Fatal Cardiovascular Disease (Fatal CVD)
Heart Failure
Abdominal Aortic Aneurysm
Peripheral Arterial Disease
Subarachnoid Haemorrhagic Stroke

First Posted Date: 2013-05-29

Last Posted Date: 2013-05-29

Lead Sponsor: University College, London

Target Recruit Count: 2240000

Registration Number: NCT01864031

Locations: 🇬🇧
University College London, London, United Kingdom

Phase I/II Trial of Antagonism of HER in GI Cancer

Phase 2

Completed

Conditions: Metastatic Colorectal Cancer
Recurrent Colorectal Cancer

Interventions: Drug: AZD8931
Drug: Irinotecan
Drug: Folinic Acid
Drug: Fluorouracil

First Posted Date: 2013-05-24

Last Posted Date: 2019-08-19

Lead Sponsor: University College, London

Target Recruit Count: 24

Registration Number: NCT01862003

Locations: 🇬🇧
University College London Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
🇬🇧
Barts Health NHS Trust, London, United Kingdom

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy